Copyright © 1994 by the European Society of Cardiology.
© 1994 The European Society of Cardiology
Na,K-pump concentration in hypertrophied human hearts





*Department of Cardiology, University of Oslo, Ullevål Hospital Norway
Institute for Experimental Medical Research, University of Oslo, Ullevål Hospital Norway
Department of Pathology, University of Oslo, Ullevål Hospital Norway
Received 14 July 1993; revised 23 March 1994; .
Correspondence. Øyvind Ellingesen, MD, PhD, Institute for Experimental Medical Research, Ullevål Hospital, N-0407 Oslo, Norway.
Abstract
Several studies have associated myocardial dysfunction with reduced myocardial Na, K-pump concentration, but whether impaired Na, K-pump capacity is a pathogenetic factor or an epiphenomenon related to accompanying cardiac hypertrophy is not established. We measured Na, K-pump concentrations in 10 hypertrophied and 11 normal weighted hearts obtained at autopsy using [3H]ouabain as ligand. Specific [3H] ouabain binding site concentration (OBC) in the left ventricle (L V) averaged 449 ± 40 (pmol. g 1 wet weight; mean ± SEM) in hypertrophied and 598 ± 36 in normal weighted ventricles (P=0.02). A trend towards lower LV OBC ( 19% P=0.25) was found in hypertrophied hearts from patients with congestive heart failure as compared with non-failing hypertrophied hearts. In multivariate analysis with 18 variables including age and heart failure, only LV weight correlated independently with LV OBC (r= 0.61; P=0.003). When OBC was related to either dry weight or to protein content, a 2535% reduction was consistently found in hypertrophied LV, whereas RV OBC was similar in both groups. In conclusion, myocardial Na, K-pump concentration and thus the capacity to maintain homeostasis is reduced in LV, but not in RV, of hypertrophied hearts. Whether the moderately reduced myocardial Na, K-pump concentration is a pathogenetic factor in LV dysfunction remains to be determined.
Key Words: Myocardium hypertrophy congestive heart failure sodium/potassium pump cardiac glycosides
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. M Pogwizd, K. R Sipido, F. Verdonck, and D. M Bers Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis Cardiovasc Res, March 15, 2003; 57(4): 887 - 896. [Full Text] [PDF] |
||||
![]() |
S. Despa, M. A. Islam, C. R. Weber, S. M. Pogwizd, and D. M. Bers Intracellular Na+ Concentration Is Elevated in Heart Failure But Na/K Pump Function Is Unchanged Circulation, May 28, 2002; 105(21): 2543 - 2548. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gao, R. S. Wymore, Y. Wang, G. R. Gaudette, I. B. Krukenkamp, I. S. Cohen, and R. T. Mathias Isoform-specific Stimulation of Cardiac Na/K Pumps by Nanomolar Concentrations of Glycosides J. Gen. Physiol., March 12, 2002; 119(4): 297 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Sejersted and G. Sjogaard Dynamics and Consequences of Potassium Shifts in Skeletal Muscle and Heart During Exercise Physiol Rev, October 1, 2000; 80(4): 1411 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Danetz, R. D. Davies, H. F. Clemo, and C. M. Baumgarten RABBIT VENTRICULAR MYOCYTE VOLUME CHANGES AS A DIRECT RESULT OF CRYSTALLOID CARDIOPLEGIA IN CONGESTIVE HEART FAILURE INDUCED BY AORTIC REGURGITATION J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 826 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Walker, F. A. Crawford Jr, and F. G. Spinale MYOCYTE CONTRACTILE DYSFUNCTION WITH HYPERTROPHY AND FAILURE: RELEVANCE TO CARDIAC SURGERY J. Thorac. Cardiovasc. Surg., February 1, 2000; 119(2): 388 - 400. [Full Text] [PDF] |
||||
![]() |
A. D Wickenden, R. Kaprielian, Z. Kassiri, J. N Tsoporis, R. Tsushima, G. I Fishman, and P. H Backx The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure Cardiovasc Res, February 1, 1998; 37(2): 312 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A Schmidt and K. Kjeldsen Human myocardial Na,K-ATPase -- quantification, regulation and relation to Ca Cardiovasc Res, February 1, 1998; 37(2): 335 - 345. [Full Text] [PDF] |
||||




